Top compounds associated with response to KMT2C


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.15 3e-05
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.19 3e-05
mRNA KPT185 CTRPv2 pan-cancer AAC 0.17 4e-05
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.16 4e-05
Download CSV